Prof. Akiko Iwasaki on X: "Why do we need a booster shots? This is because B cell responses induced by first dose only generates lower levels, lower affinity and short lived antibody
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants | NEJM
Vaccines | Free Full-Text | The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Antibody Responses and Reactogenicity of a Heterologous, Full-Dose Messenger RNA-1273 Booster in Heavily SARS-CoV-2–Exposed CoronaVac-Vaccinated Health-Care Workers in Indonesia: A Real-World Observational Study in: The American Journal of Tropical ...
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases | Annals of Hepatology
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination | Microbiology Spectrum
Boosting immunity to Omicron | Nature Medicine
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant - ScienceDirect
JCI - Durability of immune responses to mRNA booster vaccination against COVID-19
Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint | medRxiv
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years - The Lancet Regional
Frontiers | Studying the effects of booster shots and antibody responses to the SARS-CoV-2 vaccination over time in health personnel
Antibody titers in turkeys increase after multiple booster vaccinations with an attenuated Salmonella live vaccine | BMC Research Notes | Full Text
Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses - ScienceDirect
Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe
Epitope masking may limit antibody boosting to malaria vaccines - Kurtovic - 2021 - Immunology & Cell Biology - Wiley Online Library
The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study | medRxiv
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel | Infection
